{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:25:34Z","timestamp":1722889534048},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,2,17]],"date-time":"2007-02-17T00:00:00Z","timestamp":1171670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2007,3,6]]},"DOI":"10.1007\/s10096-007-0267-7","type":"journal-article","created":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T09:02:22Z","timestamp":1171616542000},"page":"167-174","source":"Crossref","is-referenced-by-count":15,"title":["Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999\u20132004"],"prefix":"10.1007","volume":"26","author":[{"given":"H.-X.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Andonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Enhanced Hepatitis Strain Surveillance System (c\/o Ms. Marlene Huard, Executive Assistant)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,17]]},"reference":[{"key":"267_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2005","unstructured":"Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558\u2013567","journal-title":"Lancet Infect Dis"},{"key":"267_CR2","first-page":"425","volume":"74","author":"World Health Organization","year":"1999","unstructured":"World Health Organization (1999) Hepatitis C\u2014global prevalence (update). Wkly Epidemiol Rec 74:425\u2013427","journal-title":"Wkly Epidemiol Rec"},{"key":"267_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1503\/cmaj.1030034","volume":"174","author":"T Wong","year":"2006","unstructured":"Wong T, Lee SS (2006) Hepatitis C: a review for primary care physicians. CMAJ 174:649\u2013659","journal-title":"CMAJ"},{"key":"267_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1155\/2001\/719650","volume":"12","author":"S Zou","year":"2001","unstructured":"Zou S, Zhang J, Tepper M et al (2001) Enhanced surveillance of acute hepatitis B and C in four regions in Canada, 1998 to 1999. Can J Infect Dis 12:357\u2013363","journal-title":"Can J Infect Dis"},{"key":"267_CR5","first-page":"1427","volume":"156","author":"PR Gully","year":"1997","unstructured":"Gully PR, Tepper ML (1997) Hepatitis C. CMAJ 156:1427\u20131430","journal-title":"CMAJ"},{"key":"267_CR6","first-page":"889","volume":"165","author":"DM Patrick","year":"2001","unstructured":"Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, Strathdee SA, Currie SL, Schechter MT, O\u2019Shaughnessy MV (2001) Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 165:889\u2013895","journal-title":"CMAJ"},{"issue":"Suppl 1","key":"267_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2893.2004.00570.x","volume":"11","author":"D Goldberg","year":"2004","unstructured":"Goldberg D, Anderson E (2004) Hepatitis C: who is at risk and how do we identify them? J Viral Hepatitis 11(Suppl 1):12\u201318","journal-title":"J Viral Hepatitis"},{"issue":"Suppl 1","key":"267_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(99)80381-X","volume":"31","author":"MJ Alter","year":"1999","unstructured":"Alter MJ (1999) Hepatitis C virus infection in the United States. J Hepatol 31(Suppl 1):88\u201391","journal-title":"J Hepatol"},{"key":"267_CR9","first-page":"1","volume-title":"Aboriginal health in Canada: historical, cultural, and epidemiological perspectives","author":"JB Waldram","year":"1995","unstructured":"Waldram JB, Herring DA, Young TK (1995) Aboriginal health in Canada: historical, cultural, and epidemiological perspectives. University of Toronto, Toronto, pp 1\u20139"},{"key":"267_CR10","first-page":"19","volume":"168","author":"KJ Craib","year":"2003","unstructured":"Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O\u2019Shaughnessy MV, Schechter MT (2003) Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 168:19\u201324","journal-title":"CMAJ"},{"key":"267_CR11","unstructured":"Public Health Agency of Canada (2004) HIV\/AIDS among Aboriginal persons in Canada: a continuing concern. http:\/\/www.phac-aspc.gc.ca\/publicat\/epiu-aepi\/epi_update_may_04\/9_e.html . Cited May 2005"},{"key":"267_CR12","first-page":"143","volume":"2","author":"HX Wu","year":"2005","unstructured":"Wu HX, Andonov A, Giulivi A, Goedhuis NJ, Baptiste B, Furseth J, Poliquin D, Chan JI, Bolesnikov G, Moffat B, Paton S, Wu J (2005) Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999\u20132003. Int J Med Sci 2:143\u2013146","journal-title":"Int J Med Sci"},{"key":"267_CR13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.510290311","volume":"29","author":"SA Villano","year":"1999","unstructured":"Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL (1999) Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908\u2013914","journal-title":"Hepatology"},{"key":"267_CR14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1155\/2003\/350175","volume":"17","author":"GY Minuk","year":"2003","unstructured":"Minuk GY, Uhanova J (2003) Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 17:707\u2013712","journal-title":"Can J Gastroenterol"},{"key":"267_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF03403646","volume":"95","author":"SL Bowker","year":"2004","unstructured":"Bowker SL, Soskolne CL, Houston SC, Newman SC, Jhangri GS (2004) Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a northern Alberta population. Can J Public Health 95:188\u2013192","journal-title":"Can J Public Health"},{"key":"267_CR16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1047-2797(00)00038-7","volume":"10","author":"G Howard","year":"2000","unstructured":"Howard G, Anderson RT, Russell G, Howard VJ, Burke GL (2000) Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol 10:214\u2013223","journal-title":"Ann Epidemiol"},{"issue":"Suppl 3","key":"267_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.aids.0000192068.88195.27","volume":"19","author":"AM Nyamathi","year":"2005","unstructured":"Nyamathi AM, Christiani A, Windokun F, Jones T, Strehlow A, Shoptaw S (2005) Hepatitis C virus infection, substance use and mental illness among homeless youth: a review. AIDS 19(Suppl 3):34\u201340","journal-title":"AIDS"},{"key":"267_CR18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jurban\/jti049","volume":"82","author":"B Fischer","year":"2005","unstructured":"Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, El-Guebaly N, Noel L, Tyndall M, Wild C, Mun P, Baliunas D (2005) Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 82:250\u2013266","journal-title":"J Urban Health"},{"issue":"Suppl 2","key":"267_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03403702","volume":"96","author":"N Adelson","year":"2005","unstructured":"Adelson N (2005) The embodiment of inequity: health disparities in Aboriginal Canada. Can J Public Health 96(Suppl 2):45\u201361","journal-title":"Can J Public Health"},{"key":"267_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.9.1350","volume":"91","author":"H Hagan","year":"2001","unstructured":"Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER (2001) Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 91:42\u201346","journal-title":"Am J Public Health"},{"key":"267_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","volume":"43","author":"J Wiegand","year":"2006","unstructured":"Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP; German HEP-NET Acute HCV Study Group (2006) Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET Acute-HCV-II Study. Hepatology 43:250\u2013256","journal-title":"Hepatology"},{"key":"267_CR22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","volume":"130","author":"SM Kamal","year":"2006","unstructured":"Kamal SM, Fouly AE, Kamel RR Hockenjos B, Al Tawil A, Khalifa KE, He Q, Koziel MJ, El Naggar KM, Rasenack J, Afdhal NH (2006) Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology 130:632\u2013638","journal-title":"Gastroenterology"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0267-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0267-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T03:37:46Z","timestamp":1587353866000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0267-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,17]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3,6]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0267-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2007,2,17]]}}}